Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
JADE1 adjacent regulatory RNA |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||||
|
Breast cancer, 11;22 translocation associated |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | |||||||||||
|
small nucleolar RNA, C/D box 28 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||||
|
chorionic gonadotropin subunit beta 7 | 5.3E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.400 | None | 1.000 | 22 | 0 | 1987 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.700 | None | 0.984 | 257 | 90 | 1982 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.400 | None | 0.963 | 27 | 0 | 1996 | 2018 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.100 | None | 0.987 | 76 | 0 | 1996 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
group | 0.340 | None | 1.000 | 7 | 0 | 2005 | 2018 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
group | 0.350 | None | 1.000 | 6 | 0 | 1997 | 2018 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.100 | None | 0.960 | 25 | 1 | 1991 | 2017 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
group | 0.370 | None | 1.000 | 8 | 0 | 1996 | 2015 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.400 | None | 0.978 | 46 | 0 | 1998 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.500 | None | 0.978 | 89 | 34 | 2004 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.400 | None | 0.988 | 85 | 1 | 1990 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.500 | None | 0.955 | 22 | 0 | 1995 | 2018 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.957 | 23 | 0 | 2000 | 2018 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.500 | None | 1.000 | 43 | 9 | 1998 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.400 | None | 0.967 | 30 | 0 | 2001 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
group | 0.400 | None | 1.000 | 19 | 0 | 2004 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.400 | None | 1.000 | 44 | 1 | 2002 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
group | 0.400 | None | 1.000 | 53 | 0 | 2001 | 2018 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
group | 0.400 | None | 1.000 | 40 | 1 | 1990 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 28 | 0 | 2004 | 2020 |